Cover Image

Reforming the Drug Compounding Regulatory Framework.

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Format:	Government Document eBook
Language:	English
Published:	Bethesda, Md. : ProQuest, 2013.
Subjects:	United States. > Food and Drug Administration. Drugs > Dosage forms > United States. Pharmaceutical industry > Government policy > United States. Medical policy > United States.
Online Access:	Electronic resource (PDF)

Similar Items

Drug compounding: FDA authority and possible issues for Congress : other title information /
by: Dabrowska, Agata
Published: (2018)

Examining Drug Compounding.
Published: (2013)

Reforming the drug compounding regulatory framework : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, July 16, 2013.
Published: (2014)

Compounded drugs /
by: Glassgold, Judith M., 1957-
Published: (2019)

Examining drug compounding : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, May 23, 2013.
Published: (2014)

Drug compounding for animals : FDA could improve oversight with better information and guidance : report to congressional committees.
Published: (2015)

Pharmaceutical Compounding : Proposed Legislative Solution.
Published: (2013)

Examining Implementation of the Compounding Quality Act.
Published: (2018)

Compounded drugs under Medicare Part B : payment and oversight.
Published: (2014)

Ansel's pharmaceutical dosage forms and drug delivery systems /
by: Allen, Loyd V., Jr, et al.
Published: (2023)

Drug delivery : principles and applications /
Published: (2016)

Regulatory exclusivity reform in the 115th Congress /
by: Thomas, John R., 1967-
Published: (2019)

Protecting the Public Health : Examining FDA's Initiatives and Priorities.
Published: (2014)

A practical guide to contemporary pharmacy practice and compounding /
by: Elder, Deborah Lester
Published: (2018)

Drug compounding, FDA has taken steps to implement compounding law, but some states and stakeholders reported challenges : report to Congressional Committees.
Published: (2016)

Developments in the Prescription Drug Market : Oversight.
Published: (2016)

Examining Concerns Regarding FDA's Proposed Changes to Generic Drug Labeling.
Published: (2014)

Memorandum report : high-risk compounded sterile preparations and outsourcing by hospitals that use them.
Published: (2013)

Federal and state role in pharmacy compounding and reconstitution : exploring the right mix to protect patients : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, first session, on examining state and federal oversight to ensure the safety and quality of drug compounding--the process of mixing, combining, or altering ingredients to create a customized medication for an individual patient--by pharmacies, October 23, 2003.
Published: (2004)

Federal and state role in pharmacy compounding and reconstitution : exploring the right mix to protect patients : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, first session, on examining state and federal oversight to ensure the safety and quality of drug compounding--the process of mixing, combining, or altering ingredients to create a customized medication for an individual patient--by pharmacies, October 23, 2003.
Published: (2004)

Specialized drug delivery systems : manufacturing and production technology /
Published: (1990)

Oral formulation roadmap from early drug discovery to development /
Published: (2017)

Access to unapproved drugs : FDA policies on compassionate use and emergency use authorization /
by: Thaul, Susan
Published: (2018)

FDA Checkup : Drug Development and Manufacturing Challenges.
Published: (2013)

Examining the Increase in Drug Shortages.
Published: (2011)

A Continuing Investigation into the Fungal Meningitis Outbreak and Whether It Could Have Been Prevented.
Published: (2013)

Drug compounding : clear authority and more reliable data needed to strengthen FDA oversight : report to congressional requesters.
Published: (2013)

Securing the Pharmaceutical Supply Chain.
Published: (2011)

Medicare's oversight of compounded pharmaceuticals used in hospitals.
Published: (2015)

Recent advances in drug delivery systems /
Published: (1984)

Drug and enzyme targeting.
Published: (1985)

Examining the Impact of Voluntary Restricted Distribution Systems in the Pharmaceutical Supply Chain.
Published: (2017)

Integrated pharmaceutics : applied preformulation, product design, and regulatory science.
by: AL-ACHI, ANTOINE
Published: (2022)

Biosimilar Implementation : A Progress Report from FDA.
Published: (2015)

Galenics of insulin : the physico-chemical and pharmaceutical aspects of insulin and insulin preparations /
by: Brange, Jens, 1940-
Published: (1987)

Pharmacy Compounding : Implications of the 2012 Meningitis Outbreak.
Published: (2012)

Assessing bioavailability of drug delivery systems : mathematical and numerical treatment /
by: Vergnaud, J. M.
Published: (2005)

The art, science, and technology of pharmaceutical compounding /
by: Allen, Loyd V., Jr
Published: (2002)

Solid state properties of pharmaceutical materials /
by: Byrn, Stephen R., et al.
Published: (2017)

Long acting animal health drug products : fundamentals and applications /
Published: (2013)